GAB2 and metabolic dysfunction-associated steatotic liver disease: In addition, deletion of Gab2 also reduced the liver weight and hepatic lipid accumulation in HFD-fed mice (Fig. 2A, B and Supplemental Fig. 2C, D), which have been proved by our laboratory group in a NAFLD mouse model31.